Tag

Nvax

All articles tagged with #nvax

Novavax Inc Faces Revenue Challenges Despite Cost Cuts
finance1 year ago

Novavax Inc Faces Revenue Challenges Despite Cost Cuts

Novavax Inc reported mixed financial results for Q4 2023 and full year 2023, with a decrease in revenue and net loss, but significant cost reductions and progress in streamlining operations. The company achieved a 30% headcount reduction and a $1.1 billion cut in operating expenses year-over-year. Despite challenges in the competitive vaccine market, Novavax provided full year 2024 revenue guidance of $800 million to $1 billion and is focusing on expanding its pipeline, with a Phase 3 COVID-19-Influenza Combination vaccine trial expected to begin in the second half of 2024.

Novavax Stock: Fluctuations, Soaring, Short Selling, and Trending with Trump's SPAC Partner
stock-market2 years ago

Novavax Stock: Fluctuations, Soaring, Short Selling, and Trending with Trump's SPAC Partner

Novavax shares fell over 8% after a previous surge in price following the FDA's Emergency Use Authorization for the company's updated protein-based COVID-19 vaccine for individuals aged 12 and older. The pullback in stock comes as the FDA has also approved updated vaccines from Moderna and Pfizer-BioNTech for the fall, all of which are expected to provide protection against current strains of the virus.

Novavax Stock Soars on Promising COVID-19 Vaccine Updates
finance2 years ago

Novavax Stock Soars on Promising COVID-19 Vaccine Updates

Novavax shares traded higher as rising COVID-19 cases in the US have boosted vaccine stocks. The dominant strain in the US is the EG.5 variant, while a highly mutated strain called BA.2.86 is being monitored. COVID tests seem effective against these variants, but it remains to be seen if a strain becomes more widespread. Fall 2023 boosters appear to work for new variants, but it is unknown if they will be effective against BA.2.86's mutations. Novavax shares closed 10.23% higher at $9.25.